Acciones Shanrong Biotechnology Corp. Other OTC
Acciones
SRBT
US81946R1077
Holding Companies
Ventas 2008 | 692 mil 638 mil | Ventas 2009 | 1,32 M 1,22 M | Capitalización | 11,62 M 10,7 M |
---|---|---|---|---|---|
Resultado Neto 2008 | -2 M -1,84 M | Resultado Neto 2009 | -5 M -4,61 M | VE / Ventas 2008 | 45,1 x |
Deuda neta 2008 | 2,53 M 2,33 M | Deuda neta 2009 | 2,18 M 2,01 M | VE / Ventas 2009 | 10,4 x |
P/E ratio 2008 |
-10,5
x | P/E ratio 2009 |
-2,03
x | Empleados | - |
Rendimiento 2008 * |
-
| Rendimiento 2009 |
-
| Flotante | 38,95 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 31/08/21 |
Qingping Zheng
BRD | Director/Board Member | - | - |
Guenter Volgger
PRN | Corporate Officer/Principal | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 31/08/21 |
Qingping Zheng
BRD | Director/Board Member | - | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+176,46 % | 6960,11 M | |
+2,19 % | 982 M | |
+41,91 % | 872 M | |
+31,32 % | 830 M | |
+1,72 % | 664 M | |
+5,92 % | 642 M | |
-.--% | 600 M | |
+3,61 % | 503 M | |
-.--% | 500 M |